High Resolution Melting Analysis Market Size is Estimated to USD 653.05 Million by 2032

Market Overview The global market for high resolution melting analysis (HRMA) had a valuation of USD 370.51 million in 2022 and is expected to reach USD 653.05 million by 2032, exhibiting a compound annual growth rate (CAGR) of 6.5% during the forecast period. Key drivers of this market growth include the increasing prevalence of chronic illnesses, a growing demand for personalized medicine, and advancements in molecular diagnostics technology. HRMA is a powerful tool in molecular biology used for methylation analysis, mutation detection, and genotyping.

The demand for molecular diagnostic tests, including HRMA, is on the rise due to the increasing incidence of chronic diseases like cancer and genetic abnormalities. According to the World Health Organization (WHO), cancer was the second leading cause of global mortality in 2018, with an estimated 9.6 million deaths. HRMA provides a quick, accurate, and cost-effective method for detecting gene mutations associated with cancer and other genetic disorders. Furthermore, HRMA can identify genetic variations that can predict an individual’s response to specific treatments, paving the way for tailored medicine.

Get a sample copy of the High Resolution Melting Analysis Market report: https://www.reportsanddata.com/download-free-sample/7017

The adoption of HRMA is being accelerated by advancements in molecular diagnostics technologies, such as Digital Polymerase Chain Reaction (PCR) and next-generation sequencing. Integration with HRMA has enhanced the accuracy, sensitivity, and specificity of molecular diagnostics, making it a reliable and popular option for gene mutation detection and genotyping. Automated HRMA systems, such as the Rotor-Gene Q from QIAGEN, have reduced manual labor requirements and increased throughput, making HRMA a more cost-effective and efficient solution for high-volume testing.

Market growth is hindered by several factors, including a shortage of qualified personnel with expertise in molecular diagnostics and the high cost of HRMA equipment and reagents. In some regions, the introduction of HRMA is hampered by a lack of knowledgeable specialists in the field of molecular diagnostics. Expensive equipment and reagents, particularly in low- and middle-income countries, also hinder the implementation of HRMA.

Government Regulations: Various regulatory bodies worldwide have established guidelines and protocols for the use of HRM analysis in medical laboratories, ensuring accuracy and safety in diagnosis, treatment, and patient monitoring.

Product Types: During the forecast period, the instruments segment is expected to dominate the HRMA market, driven by the increasing demand for HRMA equipment in molecular diagnostics and personalized medicine. HRMA tools are ideal for diagnostic applications due to their high sensitivity and specificity in detecting genetic changes. Advanced HRMA tools with features such as real-time monitoring, automation, and high-throughput capabilities are expected to further boost market revenue.

The reagents and consumables segment is anticipated to experience significant growth, driven by their extensive use in research and diagnostic facilities. The availability of a wide range of reagents and consumables, including PCR master mixes, DNA polymerases, and fluorescent dyes, contributes to the growing demand in this segment. HRMA’s expanding use in applications such as genotyping, mutation detection, and gene expression analysis also fuels revenue growth.

The software segment is projected to witness strong growth, as the demand for data analysis and interpretation in research and diagnostic laboratories increases. HRMA software plays a crucial role in data analysis, offering features like real-time data analysis, visualization, and interpretation. The availability of advanced HRMA software with capabilities like machine learning and artificial intelligence is expected to accelerate revenue growth in this segment.

Applications: Diagnostics are expected to account for the largest share of revenue in the HRMA market during the forecast period. The increasing incidence of chronic diseases, such as cancer, cardiovascular disorders, and infectious diseases, drives the demand for HRMA in diagnostic applications. HRMA’s high sensitivity and specificity make it an ideal technique for diagnostic purposes. The availability of advanced HRMA tools and software with real-time monitoring and data analysis features further supports market revenue growth.

The mutation detection market is projected to expand significantly during the forecast period, driven by HRMA’s high sensitivity and specificity in detecting genetic variants. HRMA is the preferred technology for applications requiring the rapid and cost-effective identification of gene alterations. Advanced HRMA tools and software with features like automated data analysis and real-time monitoring further fuel revenue growth.

The other applications category is expected to see moderate growth, primarily fueled by HRMA’s expanding use in various research applications, including genotyping, gene expression analysis, and DNA fingerprinting. The availability of advanced HRMA tools and software with high throughput and automated data processing capabilities contributes to revenue growth in this segment.

Regions: In 2022, the North American market led the global HRMA market in terms of revenue. North America is expected to maintain its leadership during the forecast period, driven by a growing emphasis on precision medicine, customized healthcare, and drug discovery. The region’s strong demand for HRMA technology stems from its ability to quickly and effectively identify genetic variants, mutations, and epigenetic changes. Major industry players like Thermo Fisher Scientific and Bio-Rad Laboratories are expected to support market expansion through strategic alliances and partnerships.

The European market is expected to grow at a modest rate throughout the forecast period, driven by the aging population, increasing chronic disease incidence, and rising healthcare costs. Key countries like Germany, France, and the UK are anticipated to contribute significantly to market growth, with large competitors and investments in R&D activities playing a crucial role. Adoption of cutting-edge technology in the healthcare industry and a focus on precision medicine are additional factors fueling market growth in Europe.

Competitive Landscape: Key players in the HRMA market include:

  1. Thermo Fisher Scientific Inc.
  2. Bio-Rad Laboratories, Inc.
  3. Qiagen N.V.
  4. Roche Diagnostics International Ltd.
  5. Meridian Bioscience, Inc.
  6. Agilent Technologies, Inc.
  7. Quidel Corporation
  8. Hoffmann-La Roche Ltd.
  9. Bioneer Corporation
  10. GenScript Biotech Corporation

Strategic Developments:

  • Thermo Fisher Scientific acquired PPD, Inc. in May 2021, expanding its capabilities in the biopharma market.
  • Bio-Rad Laboratories launched the SARS-CoV-2 Variant RT-PCR Assay in January 2021, using HRM technology for detecting COVID-19 variants.

Explore Trending Reports:

Masterbatch Market-https://www.globenewswire.com/news-release/2019/07/16/1883412/0/en/Masterbatch-Market-To-Reach-USD-17-35-Billion-By-2026-Reports-And-Data.html

High-Temperature Composite Resin Market-https://www.globenewswire.com/news-release/2019/09/09/1913000/0/en/High-Temperature-Composite-Resin-Market-To-Reach-USD-1-63-Billion-By-2026-Reports-And-Data.html

Seam Tapes Market-https://www.globenewswire.com/news-release/2019/09/23/1919346/0/en/Seam-Tape-Market-To-Reach-USD-188-8-Million-By-2026-Reports-And-Data.html

Fatty Acid Methyl Ester (FAME) Market-https://www.globenewswire.com/news-release/2020/01/22/1973398/0/en/Fatty-Acid-Methyl-Ester-FAME-Market-To-Reach-USD-27-8-Billion-By-2026-Reports-And-Data.html

Request a customization of the report: https://www.reportsanddata.com/request-customization-form/7017

Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.

About Reports and Data    

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report

Browse Latest Blogs: https://www.reportsanddata.com/blogs

Browse Latest Press Release: https://www.reportsanddata.com/press-release